U.S. Software Stock News

NasdaqGS:DSGR
NasdaqGS:DSGRTrade Distributors

A Look At Distribution Solutions Group (DSGR) Valuation After Q1 Sales Growth But Profit Slide

Q1 earnings put profitability in focus Distribution Solutions Group (DSGR) drew fresh attention after reporting first quarter 2026 earnings, with sales of US$496 million compared with US$478.03 million a year earlier and net income of US$0.382 million versus US$3.26 million. See our latest analysis for Distribution Solutions Group. The recent Q1 report, which paired higher sales with much lower net income, comes as the stock trades at US$27.21 and shows a 7.89% 1 year total shareholder return...
NYSE:HLF
NYSE:HLFPersonal Products

The Bull Case For Herbalife (HLF) Could Change Following Balance Sheet Refinancing And Brand Perception Shift

Herbalife recently completed a US$1.45 billion senior secured refinancing, issuing US$800.00 million of 7.750% notes due 2033, replacing its 2024 credit facility with new loans maturing in 2031, and using the proceeds to retire higher-cost debt, which is expected to reduce annual cash interest payments by about US$45.00 million. Alongside this balance sheet reshaping, Herbalife’s push into personalized nutrition, product quality recognition in India, and increased institutional ownership are...
NasdaqGS:CAR
NasdaqGS:CARTransportation

A Look At Avis Budget Group (CAR) Valuation After Short Squeeze Volatility And Upgraded 2026 Outlook

Avis Budget Group (CAR) is back in focus after a volatile short squeeze linked to market manipulation claims, just as Q1 2026 results showed tighter fleet control, higher utilization, and raised full year adjusted EBITDA guidance. See our latest analysis for Avis Budget Group. The recent short squeeze and market manipulation claims have knocked the share price back, with a 1 day share price return of a 9.3% decline and a 30 day share price return of an 11.6% decline. However, the 90 day share...
NYSE:FIGS
NYSE:FIGSLuxury

Assessing FIGS (FIGS) Valuation After A Sharp Pullback And Strong Longer Term Gains

FIGS stock in focus after recent performance shift FIGS (FIGS) is drawing attention after a recent pullback, with the stock down 9.3% over the past day and 10.5% over the past week, following a strong past 3 months. See our latest analysis for FIGS. The recent pullback sits against a much stronger backdrop, with a 30 day share price return showing a 4.7% decline, a 90 day share price return of 29.0% and a 1 year total shareholder return of about 3x. Recent moves suggest momentum has cooled in...
NYSE:UAMY
NYSE:UAMYMetals and Mining

A Look At United States Antimony’s Valuation As Rare Earths Rally And New Supply Deal Lift Expectations

United States Antimony (UAMY) has moved sharply in line with broader rare earth and critical minerals enthusiasm, after investors focused on a new five year antimony trioxide supply agreement worth up to US$106.7 million. See our latest analysis for United States Antimony. At a latest share price of US$11.75, United States Antimony has paired a strong year to date share price return of 98.15% with a very large three year total shareholder return, although the recent 1 day share price decline...
NYSE:HL
NYSE:HLMetals and Mining

Hecla Mining ESG Progress And Valuation Gap In Focus For Investors

Hecla Mining (NYSE:HL) has released its 2025 Sustainability Report, highlighting progress across environmental, social, and governance priorities. The report outlines responsible mining practices, improved safety performance, and a direct economic contribution to local communities. Hecla also details its work with indigenous communities and its role in critical mineral production for future supply chains. For investors tracking precious metals producers, Hecla Mining sits at the...
NYSE:CLH
NYSE:CLHCommercial Services

A Look At Clean Harbors (CLH) Valuation As Earnings Approach After Previous Beat

Investor focus ahead of Clean Harbors earnings Clean Harbors (CLH) is back in the spotlight as it prepares to report earnings this Wednesday before the bell, following a prior quarter that beat revenue and EPS estimates with 4.8% year-on-year revenue growth. Analysts now expect 2.7% revenue growth for the upcoming quarter, with estimates largely reconfirmed. This puts the emphasis on how the new results and outlook might influence sentiment toward the stock. See our latest analysis for Clean...
NasdaqGS:NBIS
NasdaqGS:NBISSoftware

Nebius Group (NBIS) Is Up 21.7% After $643 Million Eigen AI Deal Reshapes Cloud Stack

Nebius Group N.V. has already agreed to acquire Eigen AI in a roughly US$643 million cash-and-stock deal, integrating its inference and post‑training optimisation technology directly into Nebius’s Token Factory managed AI platform and creating a new engineering hub in the San Francisco Bay Area. This move marks a meaningful push toward a more vertically integrated AI cloud stack, aiming to improve GPU efficiency, lower inference costs, and support Nebius’s shift toward higher‑margin platform...
NYSE:GTY
NYSE:GTYRetail REITs

Does Getty Realty’s Stronger Q1 2026 Earnings Shift The Bull Case For GTY?

In April 2026, Getty Realty Corp. reported past first‑quarter 2026 results showing sales of US$57.39 million, revenue of US$57.84 million, and net income of US$26.63 million, all higher than the prior year, with basic and diluted EPS from continuing operations at US$0.43 versus US$0.25 a year earlier. The sharp increase in net income and earnings per share highlights how Getty Realty’s existing portfolio is currently converting higher revenue into stronger profitability. Next, we’ll examine...
NYSE:KNX
NYSE:KNXTransportation

A Look At Knight-Swift (KNX) Valuation After Its US$1b Convertible Notes Offering

Knight-Swift Transportation Holdings (KNX) has drawn investor attention after announcing a US$1b offering of convertible senior unsecured notes due 2031. The proceeds are earmarked for repaying existing term loans and revolving credit balances. See our latest analysis for Knight-Swift Transportation Holdings. The stock has been under some pressure in the very short term, with a 1 day share price return of 2.91% and a 7 day share price return of 3.94%. It still sits at US$62.14 after a 30 day...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

R&D Leadership Transition and Trial Continuity Could Be A Game Changer For ACADIA Pharmaceuticals (ACAD)

In late April, ACADIA Pharmaceuticals announced that Head of Research and Development Elizabeth H.Z. Thompson, Ph.D., will retire for personal reasons but remain in her role until a successor is named and continue as a consultant through at least the end of 2026, supporting continuity around key remlifanserin Phase 2 and early Phase 3 milestones. This planned transition, alongside confirmation that all ongoing trials such as the Phase 2 studies of remlifanserin in Alzheimer’s disease...
NasdaqGS:CABA
NasdaqGS:CABABiotechs

Assessing Cabaletta Bio (CABA) Valuation After 10 Year Cellares Supply Deal And Upcoming Rese Cel Data

Cabaletta Bio (CABA) has drawn fresh attention after entering a 10-year commercial supply agreement with Cellares for automated rese cel manufacturing, alongside upcoming clinical and translational presentations at a major gene and cell therapy meeting. See our latest analysis for Cabaletta Bio. The recent 10 year manufacturing agreement with Cellares and upcoming rese cel data presentations come on the back of strong momentum, with a 1 day share price return of 30.27% and a year to date...
NYSE:WTS
NYSE:WTSMachinery

A Look At Watts Water Technologies (WTS) Valuation As Earnings Expectations And Dividend Stability Draw Focus

Watts Water Technologies (WTS) heads into Wednesday’s earnings report with the market expecting year over year gains in both revenue and EPS, alongside a recently declared US$0.63 quarterly dividend to shareholders. See our latest analysis for Watts Water Technologies. At a share price of US$289.93, Watts Water’s recent 1 day and 7 day share price declines sit against a positive year to date share price return and a strong 1 year total shareholder return of 36.71%. This suggests that longer...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

How LeMaitre Vascular’s Latest Earnings Test Will Impact LeMaitre Vascular (LMAT) Investors

LeMaitre Vascular, a medical device maker focused on vascular surgery, recently reported its latest quarterly results after market hours, following a prior quarter in which it exceeded analysts’ revenue and EPS expectations. With the market earlier expecting about 11.4% year‑on‑year revenue growth this quarter, the company’s update is being closely watched as a test of whether its recent operating momentum and guidance strength can be maintained. We’ll now examine how this earnings report,...
NYSE:FNB
NYSE:FNBBanks

A Look At F.N.B (FNB) Valuation After Recent Share Price Strength And Long Term Returns

Event context and recent stock performance F.N.B (FNB) has attracted investor attention after recent trading, with the stock last closing at US$17.59. Over the past month, the share price shows a 4.3% gain, while the past 3 months reflect a 3.8% decline. See our latest analysis for F.N.B. For context, F.N.B's recent 4.3% 1 month share price return comes after a softer patch. However, the 1 year total shareholder return of 32.8% and 3 year total shareholder return of 84.4% indicate momentum...
NasdaqGS:FWRD
NasdaqGS:FWRDLogistics

Can Forward Air (FWRD) Turn Integration Challenges Into a More Profitable Operating Model?

Forward Air is set to report its Q1 2026 results, with Wall Street expecting a loss of US$0.37 per share on about US$620.20 million in revenue, as the company continues to work through operational integration challenges. Investor attention is now centered on how management’s update on operating ratios, segment margins, and profitability timelines might signal tangible progress in integrating recent acquisitions. Now we’ll examine how expectations for improved integration and profitability...
NasdaqGS:EA
NasdaqGS:EAEntertainment

Electronic Arts (EA) Valuation In Focus After Recent Share Moves And Strong Long Term Returns

Electronic Arts stock in focus after recent share performance Electronic Arts (EA) has attracted fresh attention after recent share moves, with the stock showing a small 1 day decline and modest shifts over the past week, month and past 3 months. See our latest analysis for Electronic Arts. Those short term share price moves sit against a much stronger backdrop, with Electronic Arts posting a 1 year total shareholder return of 30.98% and a 5 year total shareholder return of 47.34%, suggesting...
NYSE:IT
NYSE:ITIT

Stronger Q1, Higher Guidance And Bigger Buybacks Might Change The Case For Investing In Gartner (IT)

Gartner, Inc. reported past first-quarter 2026 results with revenue of US$1.51 billion, net income of US$222.34 million, and diluted EPS from continuing operations of US$3.18, alongside continued share repurchases under its long-running buyback program. Following this stronger-than-expected quarter, Gartner raised its full-year outlook for adjusted profitability and free cash flow and expanded its equity repurchase authorization to US$8.10 billion, highlighting management’s focus on capital...
NasdaqGS:FHB
NasdaqGS:FHBBanks

How First Hawaiian’s Higher Q1 2026 Earnings and Completed Buyback Will Impact First Hawaiian (FHB) Investors

First Hawaiian, Inc. reported past first-quarter 2026 results with net interest income of US$167.53 million, net income of US$67.78 million, steady net charge-offs of US$4.9 million, and confirmed a quarterly dividend of US$0.26 per share alongside completing a US$32 million share repurchase program. The combination of higher earnings, stable credit costs, ongoing shareholder returns through dividends and buybacks, and management’s emphasis on resilient funding and deposit growth offers a...
NYSE:ABR
NYSE:ABRMortgage REITs

Assessing Arbor Realty Trust (ABR) Valuation After Strong Sell Analyst Rating And Weaker Earnings Outlook

Analyst downgrade puts Arbor Realty Trust (ABR) under closer investor scrutiny Recent analyst coverage assigning Arbor Realty Trust (ABR) a strong sell rating, tied to declines in earnings estimates and projected year-over-year drops in quarterly and full-year earnings and revenue, has pulled fresh attention to the stock. See our latest analysis for Arbor Realty Trust. At a share price of $7.88, Arbor Realty Trust shows mixed momentum, with a 5.07% 1 month share price return and 3.28% 3 month...
NYSE:RJF
NYSE:RJFCapital Markets

How Investors Are Reacting To Raymond James Financial (RJF) Strong Q2 Earnings And Completed US$500M Buyback

In April 2026, Raymond James Financial, Inc. reported second-quarter revenue of US$4,262 million and net income of US$544 million, with both metrics higher than a year earlier and earnings per share rising on both a basic and diluted basis. Alongside this earnings release, the company confirmed it had completed a US$500 million share repurchase program, retiring 3,191,170 shares, which can enhance earnings per share by spreading profits over a smaller share count. Next, we’ll examine how...
NYSE:AN
NYSE:ANSpecialty Retail

A Look At AutoNation (AN) Valuation As Earnings Grow Despite Softer Vehicle Sales

AutoNation (AN) just reported first quarter 2026 results that combined softer revenue and unit sales with its fifth straight quarter of year over year adjusted EPS growth, highlighting earnings support from higher margin operations. See our latest analysis for AutoNation. The 1-year total shareholder return of 15.25% and 5-year total shareholder return of 93.73% contrast with a modest year-to-date share price return decline of 1.85%, suggesting momentum has cooled even as recent earnings and...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Weak Quarter And Lower 2026 Guidance

BioNTech's weak quarter and rising uncertainty BioNTech (BNTX) reported first quarter sales of €118.1 million and a net loss of €531.9 million, alongside higher per share losses, following earlier pressure from tariffs concerns, leadership changes and lowered 2026 revenue guidance. See our latest analysis for BioNTech. At a share price of $99.35, BioNTech has seen a 1 month share price return of 8.96%, but the 1 year total shareholder return of 1.73% decline and 5 year total shareholder...
NasdaqGS:VTRS
NasdaqGS:VTRSPharmaceuticals

Viatris’ FDA-Reviewed Weekly Contraceptive Patch Could Be A Game Changer For Viatris (VTRS)

Viatris recently showcased six presentations at the 2026 ACOG Annual Clinical & Scientific Meeting in Washington, highlighting positive Phase 3 efficacy, safety, adhesion, pharmacokinetic and cycle control data for its investigational low-dose estrogen weekly contraceptive patch. The company also secured FDA acceptance of its New Drug Application for the patch with a July 30, 2026 target action date, underscoring how women’s health innovation is becoming a more visible part of Viatris’...